AI-designed antibodies promise big boost to drug development
University of Washington team uses generative AI tool to create new functional cancer antibodies
Related reading
How AI can recode the difficult process of drug discovery
Research organisations are banking on technology to help improve the odds of approval
AI shows potential against resistant bacteria
Machine learning can speed up antibiotic design, but developers struggle to attract investors
OpenAI says new GPT-5 model speeds up research in maths and science
Development comes as tech groups bet on potential for AI to accelerate drug discovery and uncover new materials
Eli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech
Global pharmaceutical companies are aggressively searching for new medicines in China
Why is AI struggling to discover new drugs?
A generation of start-ups have failed to live up to the hype. Executives are now betting that more powerful tools will crack the…
The transformative potential of AI in healthcare
Accelerating the technology’s safe adoption in hospitals should be a priority